Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 2
2005 4
2006 7
2007 5
2008 7
2009 10
2010 4
2011 6
2012 5
2013 7
2014 13
2015 17
2016 11
2017 10
2018 16
2019 8
2020 15
2021 31
2022 24
2023 49
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.
Gatti M, Rinaldi M, Tonetti T, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: pea f. Antibiotics (Basel). 2024 Mar 25;13(4):296. doi: 10.3390/antibiotics13040296. Antibiotics (Basel). 2024. PMID: 38666972 Free PMC article.
Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed to improve the outcome of post-neurosurgical extensively/multidrug-resistant Gram-negative bacteria-related meningitis/ventriculitis in the current era of novel beta-lactams and beta-lactam/beta-lactamase inhibitor combinations?
Gatti M, Virgili G, Viale P, Pea F. Gatti M, et al. Among authors: pea f. Int J Antimicrob Agents. 2024 Apr 19;63(6):107177. doi: 10.1016/j.ijantimicag.2024.107177. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38643849 No abstract available.
In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis".
Gatti M, Cosentino F, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: pea f. Int J Antimicrob Agents. 2024 Apr 4;63(6):107168. doi: 10.1016/j.ijantimicag.2024.107168. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38582401 No abstract available.
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study.
Rinaldi M, Gatti M, Tonetti T, Nocera D, Ambretti S, Berlingeri A, Nigrisoli G, Pierucci E, Siniscalchi A, Pea F, Viale P, Giannella M. Rinaldi M, et al. Among authors: pea f. Ann Intensive Care. 2024 Mar 6;14(1):36. doi: 10.1186/s13613-024-01271-9. Ann Intensive Care. 2024. PMID: 38448761 Free PMC article.
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales.
Cojutti PG, Pai MP, Tonetti T, Siniscalchi A, Viale P, Pea F. Cojutti PG, et al. Among authors: pea f. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0140423. doi: 10.1128/aac.01404-23. Epub 2024 Feb 27. Antimicrob Agents Chemother. 2024. PMID: 38411995 Free PMC article.
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment.
Amadesi S, Gatti M, Rinaldi M, Pea F, Viale P, Gaibani P. Amadesi S, et al. Among authors: pea f. Int J Antimicrob Agents. 2024 Apr;63(4):107107. doi: 10.1016/j.ijantimicag.2024.107107. Epub 2024 Feb 6. Int J Antimicrob Agents. 2024. PMID: 38325723 No abstract available.
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteria.
Bonazzetti C, Rinaldi M, Cosentino F, Gatti M, Freire MP, Mularoni A, Clemente WT, Pierrotti LC, Aguado JM, Grossi P, Pea F, Viale P, Giannella M; European Study Group of Infections in Immunocompromised Host. Bonazzetti C, et al. Among authors: pea f. Transpl Infect Dis. 2024 Apr;26(2):e14238. doi: 10.1111/tid.14238. Epub 2024 Jan 24. Transpl Infect Dis. 2024. PMID: 38265107
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study.
Gatti M, Bonazzetti C, Pascale R, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: pea f. Microorganisms. 2024 Jan 12;12(1):151. doi: 10.3390/microorganisms12010151. Microorganisms. 2024. PMID: 38257978 Free PMC article.
244 results